Table 6.
T-cell clonality status on the skin, blood, and lymph nodes.
| Skin | Blood | Lymph node | ||
|---|---|---|---|---|
| Psoriasis | Positive (%) | 0 | 0 | ND |
| Negative (%) | 10 (90.9) | 10 (100) | ND | |
| Inconclusive (%) | 1 (9.1) | 0 | ND | |
| Eczema | Positive (%) | 3 (9.1) | 2 (8.3) | 0 |
| Negative (%) | 30 (90.9) | 21 (87.5) | 5 (100) | |
| Inconclusive (%) | 0 | 1 (4.2) | 0 | |
| AD | Positive (%) | 1 (10.0) | 0 | 0 |
| Negative (%) | 9 (90.0) | 7 (87.5) | 1 (100) | |
| Inconclusive (%) | 0 | 1 (12.5) | 0 | |
| Drug eruption | Positive (%) | 1 (6.2) | 1 (11.1) | ND |
| Negative (%) | 15 (93.7) | 8 (88.9) | ND | |
| Inconclusive (%) | 0 (0) | 0 | ND | |
| SS | Positive (%) | 22 (73.3)* | 30 (90.9)* | 15 (88.2)* |
| Negative (%) | 7 (23.3) | 3 (9.1) | 2 (11.8) | |
| Inconclusive (%) | 1 (3.3) | 0 | 0 | |
| MF | Positive (%) | 6 (50.0)* | 5 (33.3) | 2 (50.0)* |
| Negative (%) | 6 (50.0) | 8 (53.3) | 2 (50.0) | |
| Inconclusive (%) | 0 | 2 (13.3) | 0 | |
| Miscellaneous** | Positive (%) | 3 (33.3) | 2 (20.0) | 0 |
| Negative (%) | 5 (55.6) | 8 (80.0) | 1 (100) | |
| Inconclusive (%) | 1 (11.1) | 0 | 0 | |
| Idiopathic | Positive (%) | 3 (6.8) | 5 (11.9) | 0 |
| Negative (%) | 41 (93.2) | 36 (85.7) | 8 (100) | |
| Inconclusive (%) | 0 | 1 (2.4) | 0 | |
| Total | Positive (%) | 39 (23.6) | 45 (29.8) | 17 (47.2) |
| Negative (%) | 123 (74.5) | 101 (66.9) | 19 (52.8) | |
| Inconclusive (%) | 3 (1.8) | 5 (3.3) | 0 |
*P < 0.001.
** ATLL: positive clonality on the skin 2 (66.7%); positive clonality on the blood 1 (50%).
ND: not done.